On 10th October 2012, Ovacome, in collaboration with other gynaecological charities and healthcare professional, published an open letter in the Scotsman, calling on Alex Neil MSP (Cabinet Secretary for Health and Well-Being) to express our concern following the decision by the Scottish Medicines Consortium (SMC) not to approve the availability of bevacizumab (Avastin) for women with ovarian cancer in Scotland.
A copy of the letter can be downloaded from our website here:
We are calling on all our members to write to Ovacome if you feel you support the action the letter is calling for. Then all of your letters can be sent on to Mr Neil to help with getting the situation changed.
If you are affected by this issue in Scotland and would like to add your voice to ours, please forward your letter to:
Ovacome, B5 City Cloisters, 196 Old Street, London EC1V 9FR
Or email us at email@example.com
Thank you for your support.